.jpg?width=690&height=468&name=AI-optimized-solutions-for-pricing-and-contracting-decisions%20(1).jpg)
AI-optimized solutions for pricing and contracting decisions
Standardize contract evaluation, streamline data flows, and automate analytics throughout the contract management life cycle.
Pricing and contracting analytics
As life sciences companies operate in a managed care environment, they generate heaps of data across channels, structure, and granularity. These data sources include sales, admin, brand performance, and member utilization data. This data is appended with the growing need for real-world evidence, which is used to generate treatment outcomes publications. A non-standardized and manual process to harness this data can adversely affect companies’ pricing and contracting decisions, leading to under-preferred deal negotiations.
Axtria’s data-driven and AI/ML-based pricing and contracting solutions help improve contract evaluation, streamline data, and automate analytics workflows throughout the contract management life cycle. These solutions help predict the expected returns on discounts and rebates and prevent lost opportunities from revenue leakage.
Maximize profit, revenue, and long-term shareholder value
Standardized data integration approach
for swift analytics insights
Transparent “no black box” approach
for operational transparency and trust
Quantitative real-world evidence (RWE)
and impact measurement
Simulations to assess future scenarios
for contracting decisions
Scalable enterprise-grade solutions
for information consistency
Savings in rebates, discounts, prevention of revenue
leakage, and AI/ML-driven confident decisions
Proven benefits from data > insights > operations
.png?width=140&height=140&name=Proven-benefits-icon1%20(1).png)
Centralized data sources and an online tool to standardize the contracting decision process.
Budget impact model to assess financial consequences of drug adoption from payers’ perspective.
Simulated scenarios for contracting and formulary changes impact on brand performance.
Axtria research hub
Blog
Unveiling the Key Trends and Topics: Axtria's Insights from ISPOR 2023
White Paper
Growing Attention Being Paid To Pharma Company Rebates And Discounts
White Paper